Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

Launched by EPIMINDER AMERICA, INC. · Aug 6, 2025

Keywords

ClinConnect Summary

This study is a long-term follow-up for people with epilepsy who have already used a device called the Minder System. The Minder System helps doctors better monitor and manage seizures, especially for those whose seizures are hard to detect with regular tests like EEGs. This research aims to see how well the Minder System supports ongoing care by collecting information about participants’ overall health, their use of healthcare, and their experience with the device over time.

To join this study, participants must have already taken part in the earlier DETECT study, received the Minder device, and completed that study’s requirements. They also need to still have the device implanted and continue meeting certain health criteria. Throughout this follow-up, participants will keep seeing their usual doctor and have check-ups every six months for up to two years after getting the Minder device. This helps doctors keep track of their epilepsy and adjust treatment as needed.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participant met all inclusion criteria, was enrolled in the DETECT study, and received the Minder device
• • Participant completed the DETECT study by receiving an actionable event or by completing the 6-month follow-up visit
• • Participant continues to have the Minder device implanted
• • Participant must continue to meet relevant DETECT study inclusion criteria
• Exclusion Criteria:
• • Participant meets any relevant DETECT study exclusion criteria including needing treatments or assessments that are not indicated with the Minder System like Magnetic Resonance Imaging (MRI)